INS and diabetes mellitus: A1 AR selective agonist, 2-chloro N6 -cyclopentyladenosine (CCPA), has been shown to alleviate diabetes by increasing insulin = stimulated glucose transport in isolated rat muscle [47, 48], and thus ruled out the possible protective effect of A1 AR antagonist against diabetes.